1. Home
  2. QUAD vs CCCC Comparison

QUAD vs CCCC Comparison

Compare QUAD & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$9.64

Market Cap

438.3M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.33

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
CCCC
Founded
1971
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.3M
404.7M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
QUAD
CCCC
Price
$9.64
$3.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$9.93
$12.20
AVG Volume (30 Days)
341.3K
1.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
5.71%
N/A
EPS Growth
150.47
16.45
EPS
0.13
N/A
Revenue
$2,419,900,000.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$73.08
N/A
Revenue Growth
N/A
1.02
52 Week Low
$5.12
$1.69
52 Week High
$11.15
$5.17

Technical Indicators

Market Signals
Indicator
QUAD
CCCC
Relative Strength Index (RSI) 41.62 38.87
Support Level $7.15 $3.38
Resistance Level $11.01 $3.91
Average True Range (ATR) 0.37 0.16
MACD -0.12 -0.03
Stochastic Oscillator 17.18 16.97

Price Performance

Historical Comparison
QUAD
CCCC

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: